(2R,2'R,3R,3'R,4S)-2,2'-bis(3,4-dihydroxyphenyl)-[4,6'-bichromane]-3,3',5,5',7,7'-hexaol

Catalog No. :
ACLJHH911
CAS No. :
12798-57-1
Molecular Formula :
C30H26O12
Molecular Weight :
578.53

IUPAC Name:(2R,2'R,3R,3'R,4S)-2,2'-bis(3,4-dihydroxyphenyl)-[4,6'-bichromane]-3,3',5,5',7,7'-hexaol

(2R,2'R,3R,3'R,4S)-2,2'-bis(3,4-dihydroxyphenyl)-[4,6'-bichromane]-3,3',5,5',7,7'-hexaol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2R,2'R,3R,3'R,4S)-2,2'-bis(3,4-dihydroxyphenyl)-[4,6'-bichromane]-3,3',5,5',7,7'-hexaol
IUPAC Name(2R,2'R,3R,3'R,4S)-2,2'-bis(3,4-dihydroxyphenyl)-[4,6'-bichromane]-3,3',5,5',7,7'-hexaol
MDL No.MFCD01732372
Molecular FormulaC30H26O12
Molecular Weight578.53
SMILESOC1=CC(O)=C2C(=C1)O[C@H](C1=CC(O)=C(O)C=C1)[C@H](O)[C@H]2C1=C(O)C2=C(C=C1O)O[C@H](C1=CC(O)=C(O)C=C1)[C@H](O)C2
InChI KeyGMISZFQPFDAPGI-CVJZBMGUSA-N
Synonym(2R,3R)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-6-[[(2R,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-3,5,7-trihydroxy-2H-1-benzopyran]-4β-yl]-2H-1-benzopyran-3,5,7-triol;(4→6)-Procyanidin B5;4β,6'-Bi[(2R)-3,4-dihydro-2α-(3,4-dihydroxyphenyl)-2H-1-benzopyran-3α,5,7-triol];Epicatechin-(4β→6)-epicatechin;Proanthocyanidin B5;[4,6'-Bi-2H-1-benzopyran]-3,3',5,5',7,7'-hexol, 2,2'-bis(3,4-dihydroxyphenyl)-3,3',4,4'-tetrahydro-, (2R,2'R,3R,3'R,4S)-
CAS No.12798-57-1

Synthetic Route by SureRoute

1. ACLJHH911 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLJHH911 route product structure diagram
    ACLJHH91112798-57-1
Inquiry

2. ACLJHH911 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLJHH911 route product structure diagram
    ACLJHH91112798-57-1
Inquiry

Comments (0)